Cefiderocol

Records for this ingredient, by country (identity only).

ATC J01DI04 · 7 markets · 7 records

Cefiderocol 7 markets · 7 records Forms
Filters

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 1,000 mg/10 mLinjectionFetroja

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 1,000 mg per mL / per unit basis not statedinjectionFetcroja 1g powder for concentrate for solution for infusion vials

AU 1 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 1,560 mg per mL / per unit basis not statedinjectionFETROJA cefiderocol (as sulfate tosilate) 1 g powder for injection vial unknown

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

  • 1,000 mg per mL / per unit basis not statedinjectionFETCROJA

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 1000 mg per mL / per unit basis not statedinjectionFETCROJA 1 g, poudre pour solution à diluer pour perfusion

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.